SCHEMBL3757772

SCHEMBL3757772

Nc1cn[c]c(-c2ccccc2)c1N1CCCCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 5/20 0.40
LMNA P02545 4/20 0.40
HTT P42858 3/20 0.40
TSHR P16473 3/20 0.40
USP2 O75604 2/20 0.40
KEAP1 Q14145 1/20 0.40
ALDH1A1 P00352 6/20 0.38
NPC1 O15118 4/20 0.38
RAB9A P51151 3/20 0.38
NOS1 P29475 1/20 0.38
HPGD P15428 5/20 0.38
KDM4E B2RXH2 4/20 0.38
MAPT P10636 3/20 0.38
NPSR1 Q6W5P4 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
ADORA2A P29274 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
GAA P10253 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3760258 0.98 HTT (0.38) HSD17B10LMNAHTTTSHRUSP2
SCHEMBL3763028 0.95 LMNA (0.35) HSD17B10LMNAHTTTSHRUSP2
SCHEMBL3759744 0.79 NPY5R (0.36) HSD17B10LMNAHTTTSHRUSP2
SCHEMBL3759329 0.77 HPGD (0.44) HSD17B10LMNAHTTTSHRUSP2
SCHEMBL3765786 0.75 HPGD (0.46) LMNAHTTTSHRALDH1A1NPC1
SCHEMBL3759709 0.74 NPY5R (0.32) HSD17B10TSHRUSP2ALDH1A1NPC1
SCHEMBL3754790 0.73 NPY5R (0.43) HSD17B10LMNAHTTTSHRKEAP1
SCHEMBL3764989 0.72 SMN1; SMN2 (0.44) HSD17B10LMNAHTTTSHRALDH1A1
SCHEMBL3751377 0.72 NPY5R (0.41) HSD17B10LMNAHTTKEAP1ALDH1A1
SCHEMBL3756111 0.71 ADORA2A (0.40) HSD17B10LMNAHTTTSHRUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA HSD17B10 2922/4885LMNA 4870/4885HTT 1234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.